Skip to content

Astrazeneca announces forxiga® will be listed on the pbs for Australians living with symptomatic heart failure with reduced ejection fraction

By Gold Cross - December 21, 2021

This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Article tags

Articles you might be interested in

Pharmacist Only
, , , ,

APP2022: Early bird closes today!

Gold Cross | January 24, 2022
Pharmacist Only
,

Researchers to explore medicinal cannabis efficacy on long COVID

Gold Cross | January 20, 2022
Pharmacist Only
, ,

TGA Approves Pfizer’s Novel COVID-19 Oral Treatment in Australia

Gold Cross | January 20, 2022
Pharmacist Only
,

Avance clinical announces major PE investment for US expansion at biotech showcase 2022

Gold Cross | January 19, 2022
BD Rowa Vmotion
BD Rowa Vmotion

Latest Posts

Pharmacist Only
APP2022: Early bird closes today!
Gold Cross | January 24, 2022
Pharmacist Only
Researchers to explore medicinal cannabis efficacy on long COVID
Gold Cross | January 20, 2022
Pharmacist Only
TGA Approves Pfizer’s Novel COVID-19 Oral Treatment in Australia
Gold Cross | January 20, 2022

Featured Posts

Employee Dishonesty
Gold Cross | January 13, 2022
The last mile: Delivery in less than 60 minutes
Gold Cross | December 7, 2021
Guild Insurance is Australia’s small general insurance company of the year
Gold Cross | November 19, 2021

Tags

Scroll To Top